EP lab ablation catheter. #HRS21 #HRS2021
August 03, 2021
Patients With Atrial Fibrillation and Heart Failure Benefit From Early Rhythm Control
August 3, 2021 — A subgroup analysis of the EAST – AFNET 4 study population revealed early initiation of rhythm control…
Read More
emporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial fibrillation (AF) after coronary artery bypass (CAGB) surgery CABG without any adverse events in a randomized pilot study. The TEmporary Spinal CoRd StiMulatIon to PrevenNt Atrial FibrillaTION AFter Cardiac Surgery (TerminationAF) study was presented as a late-breaking study presented at the 2021 Heart Rhythm meeting, the annual conference of the Heart Rhythm Society (HRS).  #HRS21 #HRS2021
August 03, 2021
Spinal Cord Stimulation Helps Suppress AF in CABG Patients
August 4, 2021 — Temporary Spinal cord stimulation (SCS) was effective in suppressing post-operative atrial…
Read More
Oral Contraceptives Cause Increased Risk of Cardiac Events in Woman With Long QT Syndrome. #HRS21 #HRS2021 #womenshealth
August 03, 2021
Oral Contraceptives Cause Increased Risk of Cardiac Events in Woman With Long QT Syndrome
August 3, 2021 – Results from a new clinical trial show an increased risk of cardiac events, like sudden cardiac death…
Read More
A recent study unveiled a novel sinus node ablation technique that provides a safe and effective treatment option for patients suffering from symptomatic, drug-resistant inappropriate sinus tachycardia (IST). Results of the Susruta-IST Registry were presented as a late-breaking clinical trial at Heart Rhythm 2021, the annual meeting of the Heart Rhythm Society (HRS). #HRS21 #HRS2021
August 03, 2021
New Hybrid Ablation Technique Safe and Effective Treatment for Patients With Inappropriate Sinus Tachycardia
August 3, 2021 – A recent study unveiled a novel sinus node ablation technique that provides a safe and effective…
Read More
The Philips EPD Kodex system for the EP lab.
August 03, 2021
Economic Analysis of CABANA Trial Reveals Economic Benefits of Catheter Ablation Compared to Drug Therapy
August 3, 2021 – A new analysis of the Catheter Ablation vs. Antiarrhythmic Drug Therapy for Atrial Fibrillation (…
Read More
The new Octaray high-density mapping catheter from Biosense Webster has 48 electrodes to enable faster and more detailed electromapping of the heart to better guide ablation procedures.
August 03, 2021
Biosense Webster Showcases New Data and Latest Innovations at Heart Rhythm 2021
August 3, 2021 – Biosense Webster, the global leader in cardiac arrhythmia treatment and part of Johnson & Johnson…
Read More
BIO-AffectDX is a multi-center, observational study that will enroll HF patients with paroxysmal, persistent and long-standing persistent AF, and a standard CRT-D indication. The study will include up to 400 participants implanted with a Biotronik Acticor CRT-DX system.
August 03, 2021
New Study Aims to Show Effectiveness of CRT-D for Heart Failure Patients With Atrial Fibrillation
August 3, 2021 — In association with Heart Rhythm 2021, Biotronik announced first enrollments in the landmark BIO-…
Read More
The Orchestra BioMed BackBeat Cardiac Neuromodulation Therapy (CNT) system is implanted similar to a pacemaker to stimulate the sympathetic nerves to help reduce blood pressure.
August 03, 2021
Significant and Sustained Reduction in Blood Pressure in MODERATO II Trial Using BackBeat Cardiac Neuromodulation Therapy in Crossover Patients
August 3, 2021 — Long-term follow-up data on hypertensive patients from the control group of the MODERATO II study who…
Read More
In an effort to contain COVID-19 and the new rapid spread of the delta virus across the U.S., a coalition of 10 cardiovascular societies issued a statement of support for healthcare systems requiring COVID-19 vaccines for its employees. ACC, HRS, ASNC, SCMR, SCCT, ASE, HFSA, STS, SCAI.
By Dave Fornell, Editor
July 30, 2021
Cardiovascular Societies Support COVID-19 Vaccines for all Healthcare Workers 
July 30, 2021 — A coalition of 10 U.S.-based cardiovascular societies have issued a statement today in support of all…
Read More
Innovative Health Inc. announced several new initiatives to increase savings from single-use device reprocessing in the electrophysiology (EP) lab. #HRS21 #HRS2021 #Heartrhythm21
July 30, 2021
Innovative Health Planning to Add Catheter Reprocessing for  Emerging EP Technologies 
July 30, 2021 – Innovative Health Inc. announced several new initiatives to increase savings from single-use device…
Read More
Results of the STROKE-VT trial showed direct oral anticoagulants (DOACs) are more effective than aspirin in reducing cerebrovascular events, including stroke in patients undergoing ventricular tachycardia ablation.
July 29, 2021
Oral Anticoagulants After Catheter Ablation Helps Reduce Stroke in High-Risk Patients
July 29, 2021 – Results of the STROKE-VT trial shows direct oral anticoagulants (DOACs) are more effective than aspirin…
Read More
The devices compared in the study were the Bardy Carnation Ambulatory Monitor long-term continuous ECG system (left) and the BioGuardian MCT cardiac event monitor (right).  #HRS21 #HRS2021 #HeartRhythm21
July 29, 2021
Human ECG Monitoring Outperforms AI Dependent Remote Cardiac Monitoring
July 29, 2021 – Results from a new clinical trial found human-oversight dependent continuous electrocardiography (ECG)…
Read More
The BardyDx Carnation Ambulatory Monitor (CAM) is a P-wave centric wearable ambulatory cardiac patch monitoring and arrhythmia detection device. 
July 29, 2021
Bardy Carnation Ambulatory Monitor Patch Decreases Diagnosis Time and Readmissions
July 29, 2021 — A recent clinical study from Overlake Medical Center utilizing the Bardy Diagnostics Carnation…
Read More
St. Jude Medical Pays $27 Million for Allegedly Selling Defective ICD and CRT-D devices
July 28, 2021
St. Jude Medical Pays $27 Million for Allegedly Selling Defective Heart Devices
July 28, 2021 — The U.S. Justice Department announced earlier this month that St. Jude Medical Inc. agreed to pay $27…
Read More
ScImage Inc., a provider of cloud-centric cardiovascular and radiology enterprise imaging and reporting solutions, announced a partnership with Cardiology Consultants PA (CCPA). The Spartanburg, S.C., cardiology group consists of 14 physicians, six nurse practitioners, three office locations and a newly opened office-based lab/ambulatory surgical center (OBL/ASC) servicing upstate South Carolina and western North Carolina. ScImage provided a CVIS, or cardiovascular information system.
July 28, 2021
ScImage Announces Cloud Install at Cardiology Consultants of Spartanburg
July 28, 2021 - ScImage Inc., a provider of cloud-centric cardiovascular and radiology enterprise imaging and reporting…
Read More
The AcQMap 3D Imaging and Mapping System, left, and the AliveCor KardiaMobile device and app for personal ECG monitoring using a smartphone, right. The companies plan to use remote monitoring to see if it helps improve care for ablation patients.
July 27, 2021
AliveCor and Acutus Partner to Evaluate Arrhythmia Management and Treatment
July 27, 2021 — AliveCor Inc., which offers FDA-cleared, smart-phone enabled personal electrocardiogram (ECG)…
Read More
July 27, 2021
Philips Receives FDA Breakthrough Device Designation for Laser Assisted IVC Filter Removal Device
July 27, 2021 — The U.S. Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to a…
Read More
Schematic illustration of a pre-vascularized stem cell patch having multiple stem cell-laden bio-inks to encorage heart cell regrowth at infarct areas. With permission from Elsevier. Read the original article.Jinah Jang, Reprinted from Biomaterials, Vol 112, Jinah Jang et al., 3D printed complex tissue construct using stem cell-laden decellularized extracellular matrix bioinks for cardiac repair, Pages 264-274, Copyright (2017),
July 27, 2021
Bioprinted 3D Cardiac Patches Could Reverse Scar Formation, Promote Myocardial Regeneration After Heart Attacks
July 27, 2021 -- Cardiovascular diseases account for 32% of global deaths. Myocardial infarction, or heart attacks,…
Read More
Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1] demonstrating a significantly lower infection risk for patients who develop hematomas after cardiac implantable electronic devices (CIEDs) when the Tyrx Absorbable Antibacterial Envelope is used at implant. The analysis showed an 82% reduction in major CIED infections among patients with the Tyrx Envelope who developed hematomas compared to patients in the control group who developed hematomas.
July 27, 2021
Tyrx Absorbable Antibacterial Envelope Effectively Reduces Infections in Cardiac Device Patients with Hematomas
July 27, 2021 — Medtronic announced new data from the landmark WRAP-IT study published in Heart Rhythm,[1]…
Read More
Images or a digital twin mitral valve of a patient created from cardiac ultrasound that were used to perform a virtual surgical procedure to test how the intervention would impact the patient prior to actually performing the procedure. The right image shows color coding for sheer stresses on the valve leaflets before and after the virtual surgery. The right image shows the model quantitation of leaflet coaptation at peak systole prior to the the virtual surgery. Read the original article in Plos One https:/
By Dave Fornell, Editor
July 26, 2021
Development of Computer Generated Virtual Hearts Using Echocardiography
Outside of medicine, computer-generated virtual twins of real machines like cars or airplanes have been used in…
Read More
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now